4//SEC Filing
Hayes Christopher G. 4
Accession 0001415889-24-008543
CIK 0001660334other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:31 PM ET
Size
7.5 KB
Accession
0001415889-24-008543
Insider Transaction Report
Form 4
Hayes Christopher G.
CHIEF LEGAL OFFICER
Transactions
- Award
Common Stock
2024-03-15+40,000→ 163,226 total - Award
Employee Stock Option (right to buy)
2024-03-15+80,000→ 80,000 totalExercise: $4.80Exp: 2034-03-15→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs shall vest in equal annual installments on March 15, 2025, March 15, 2026, March 15, 2027 and March 15, 2028 subject to the Reporting Person's continuous service through each applicable date.
- [F2]25% of the total shares subject to the option shall vest on March 15, 2025 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001805359
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:31 PM ET
- Size
- 7.5 KB